Driving innovation from discovery to access: Meeting report of the 7 th Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil).

Gates Open Research Pub Date : 2025-08-27 eCollection Date: 2025-01-01 DOI:10.12688/gatesopenres.16360.1
Shaun Palmer, Rebecca A Clark, Bridgette J Connell, Vanessa Mwebaza Muwanga, Arthur Coelho, Paul Ogongo, Carly Young
{"title":"Driving innovation from discovery to access: Meeting report of the 7 <sup>th</sup> Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil).","authors":"Shaun Palmer, Rebecca A Clark, Bridgette J Connell, Vanessa Mwebaza Muwanga, Arthur Coelho, Paul Ogongo, Carly Young","doi":"10.12688/gatesopenres.16360.1","DOIUrl":null,"url":null,"abstract":"<p><p>We urgently need novel, effective, and accessible vaccines to end tuberculosis (TB) as a public health crisis. The 7th Global Forum on TB Vaccines was convened from 8-10 October 2024 in Rio de Janeiro, Brazil. Under the theme of \"Driving innovation from discovery to access,\" the program covered the breadth of TB vaccine research and development (R&D) through implementation, while underscoring the need for greater innovation and investments to advance development and ensure rapid, affordable, and equitable access. Participants shared the latest research on: approaches to diversify the TB vaccine pipeline, candidates advancing through late-stage trials toward licensure, and efforts to ensure new TB vaccines reach the populations that most need them. The forum provided a platform to learn from diverse experts across the field, including researchers, industry, funders, civil society, and affected communities. Participants examined cross-cutting enablers throughout, including opportunities to establish novel partnership and financing models, enhance open science, optimize R&D practices, and strengthen leadership and engagement with community members and high burden countries alike. In this report, we synthesize key themes and findings from the meeting, highlighting progress and priorities in the TB vaccine field.</p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"9 ","pages":"65"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12391588/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gates Open Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/gatesopenres.16360.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We urgently need novel, effective, and accessible vaccines to end tuberculosis (TB) as a public health crisis. The 7th Global Forum on TB Vaccines was convened from 8-10 October 2024 in Rio de Janeiro, Brazil. Under the theme of "Driving innovation from discovery to access," the program covered the breadth of TB vaccine research and development (R&D) through implementation, while underscoring the need for greater innovation and investments to advance development and ensure rapid, affordable, and equitable access. Participants shared the latest research on: approaches to diversify the TB vaccine pipeline, candidates advancing through late-stage trials toward licensure, and efforts to ensure new TB vaccines reach the populations that most need them. The forum provided a platform to learn from diverse experts across the field, including researchers, industry, funders, civil society, and affected communities. Participants examined cross-cutting enablers throughout, including opportunities to establish novel partnership and financing models, enhance open science, optimize R&D practices, and strengthen leadership and engagement with community members and high burden countries alike. In this report, we synthesize key themes and findings from the meeting, highlighting progress and priorities in the TB vaccine field.

推动从发现到获取的创新:第七届结核病疫苗全球论坛会议报告(2024年10月8日至10日,巴西里约热内卢)。
我们迫切需要新型、有效和可获得的疫苗,以终结作为公共卫生危机的结核病。第七届结核病疫苗全球论坛于2024年10月8日至10日在巴西里约热内卢召开。该规划以“推动从发现到获取的创新”为主题,涵盖了结核病疫苗研发(R&D)的实施范围,同时强调需要加大创新和投资,以促进发展,确保快速、负担得起和公平获取。与会者分享了以下方面的最新研究成果:使结核病疫苗渠道多样化的方法、从后期试验推进到获得许可的候选疫苗,以及确保新的结核病疫苗能够惠及最需要疫苗的人群的努力。该论坛为向研究人员、产业界、资助者、民间社会和受影响社区等各领域专家学习提供了一个平台。与会者审议了贯穿始终的跨领域推动因素,包括建立新型伙伴关系和融资模式、加强开放科学、优化研发实践以及加强社区成员和高负担国家的领导和参与的机会。在本报告中,我们综合了会议的主要主题和结果,强调了结核病疫苗领域的进展和优先事项。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Gates Open Research
Gates Open Research Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
3.60
自引率
0.00%
发文量
90
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信